Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
paolo.marchetti@uniroma1.it
Paolo Marchetti
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
E-mail:
paolo.marchetti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence
JOURNAL OF CELLULAR PHYSIOLOGY
2020
Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma
ENDOCRINE
2020
Correction to. Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma
ENDOCRINE
2020
5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
2020
Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification
ANNALS OF ONCOLOGY
2020
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL
VACCINES
2020
The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy
VACCINES
2020
The Exponential Phase of the Covid-19 Pandemic in Central Italy: An Integrated Care Pathway
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
2020
Tobacco, alcohol and family history of cancer as risk factors of oral squamous cell carcinoma: case-control retrospective study
APPLIED SCIENCES
2020
Radiopharmaceuticals for breast cancer and neuroendocrine tumor. Two examples of how tissue characterization may influence the choice of therapy
CANCERS
2020
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study
EUROPEAN JOURNAL OF CANCER
2020
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
2020
The 5-Ws of immunotherapy in head and neck cancer
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY
2020
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1
FRONTIERS IN IMMUNOLOGY
2020
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma
CANCERS
2020
Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience
ANTI-CANCER DRUGS
2020
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: an action plan
ORAL DISEASES
2020
Tissue immune profile: a tool to predict response to neoadjuvant therapy in triple negative breast cancer
CANCERS
2020
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes
JOURNAL FOR IMMUNOTHERAPY OF CANCER
2020
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial
CANCERS
2020
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma